North America Catheters Market Outlook (2022-2033)

The North America catheters market is poised for substantial growth, projected to reach approximately US$ 66,452.4 million by 2033, up from US$ 30,116.5 million in 2024. This growth trajectory indicates a compound annual growth rate (CAGR) of 9.5% from 2025 to 2033.

Executive Summary and Market Analysis

The catheters market in North America is witnessing robust expansion, primarily driven by the increasing prevalence of chronic diseases, a rising preference for minimally invasive procedures, and ongoing technological advancements. In 2024, North America accounted for the largest share of the global catheters market revenue.

The United States, in particular, plays a significant role in this market, influenced by a combination of clinical needs, demographic shifts, and evolving healthcare delivery models. A major factor contributing to this growth is the high incidence of chronic diseases such as cardiovascular conditions, diabetes, and renal failure, which often necessitate catheter-related interventions. According to the Centers for Disease Control and Prevention (CDC), approximately 60% of adults in the U.S. live with at least one chronic disease, and there are nearly 1 million cases of catheter-associated urinary tract infections (CAUTIs) annually. This scenario has led to a surge in the adoption of permanent antimicrobial-coated catheters aimed at enhancing patient safety. Furthermore, by 2030, all baby boomers in the U.S. will be aged 65 or older, with 94% of adults over 60 living with at least one chronic condition, ensuring a sustained demand for catheter solutions. The American Hospital Association reports that hospitals, as primary end-users of catheters, recorded over 33 million admissions, many involving catheterization for surgical or intensive care purposes. The growth of home healthcare and outpatient surgical centers is also expected to drive demand for user-friendly catheters that can be self-administered.

Market Segmentation Analysis

The North America catheters market can be segmented based on product type, catheter type, coating type, lumen configuration, and end-user category.
By Product: The market is divided into cardiovascular catheters, intravenous catheters, urological catheters, specialty catheters, and neurovascular catheters. In 2024, cardiovascular catheters dominated the market, driven by the high prevalence of chronic diseases such as obesity, hypertension, and diabetes, which are significant risk factors for cardiovascular issues.
By Type: The catheter market is categorized into Foley catheters, intermittent catheters, IVUS catheters, balloon catheters, and others. The balloon catheter segment led the market in 2024, attributed to the widespread acceptance and high volume of minimally invasive procedures.
By Coating Type: The market is segmented into coated and uncoated catheters, with coated catheters leading in 2024 due to stringent regulatory oversight from organizations like the FDA, which emphasizes patient safety and infection prevention.
By Lumen: The market is divided into single-lumen and multi-lumen catheters, with multi-lumen catheters dominating in 2024. This dominance is due to the increasing complexity of patient care and the demand for efficient drug delivery in critical care settings.
By End User: The market is segmented into hospitals & clinics, home care settings, ambulatory surgical centers, diagnostic imaging centers, and others. Hospitals and clinics held the largest market share in 2024, as they serve as central hubs for major surgical and specialized procedures.

Market Outlook

The North America catheters market is influenced by several factors, including the high prevalence of chronic lifestyle-related diseases, a robust healthcare infrastructure, and a strong focus on technological innovation. There is a notable trend towards home healthcare, driven by cost containment and patients' preferences for comfort and convenience. The increasing use of self-catheter products, particularly in urology, is propelling market growth. Future developments in the catheter market will likely be characterized by the integration of smart technologies, including AI-driven analytics and real-time sensors, enhancing precision and patient monitoring. Medical device companies are investing heavily in R&D to develop next-generation catheters with improved biocompatibility, coatings, and drug delivery functionalities, ensuring that the region remains a leader in medical technology innovation.

Country Insights

The North America catheters market is segmented into the United States, Canada, and Mexico. The U.S. held the largest market share in 2024. The market dynamics in these countries vary significantly. The U.S. is the most developed market, characterized by advanced healthcare systems and a high volume of surgical procedures, supported by regulations that foster innovation. Canada’s publicly funded healthcare system emphasizes cost-effective, high-quality single-use catheters, prioritizing infection control and patient safety. Mexico, as an emerging market, shows significant growth potential, driven by an expanding middle class and increasing access to private healthcare and medical tourism.

Company Profiles

Key players in the catheters market include Medtronic Plc, Boston Scientific Corporation, Becton, Dickinson and Co., Teleflex Incorporated, B. Braun SE, Abbott Laboratories, Terumo Corporation, Coloplast Group, Cook Medical, and Hollister Incorporated. These companies are focusing on strategies such as expansion, product innovation, and mergers and acquisitions to maintain competitiveness and deliver innovative products to consumers. Show more